Last Updated

14 Dec 2018

Review of Mass Drug Administration and Primaquine Use

Click on the image above to open the resource:

Review of Mass Drug Administration and Primaquine Use

This background paper is a rapid synthesis of current evidence prepared for the Bill & Melinda Gates Foundation to inform strategy development.

Related Resources
Report
|

WHO Vector Control Advisory Group meeting report: 28–30 March, 2022

World Health Organization (WHO)

Guidance & Strategy
|

The use of rectal artesunate as a pre-referral treatment for severe Plasmodium falciparum malaria, 2023 update

World Health Organization (WHO)

Related Projects

- | $1.64M

Managing insecticide resistance in Burkina Faso and Côte d'Ivoire: researches on new vector control strategies
Expertise France, Institute of Research for Development (IRD), France | Cédric Pennetier | Burkina Faso, Côte d'Ivoire
- | $425k

Personalising anti malaria therapy through hand-held point of care nanotechnology devices
Swedish Research Council (SRC), Sweden, Karolinska Institute (KI), Sweden | Jose Pedro Gil | Sweden
Themes
Challenges in Elimination
Drug-based Strategies
Author(s)
University of California San Francisco (UCSF), USA

Collaborator(s)

Centers for Disease Control and Prevention (CDC), USA
U.S. President's Malaria Initiative (PMI), USA

Date Published